• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    United Therapeutics Corporation (UTHR)

    -NasdaqGS
    133.56 Up 2.45(1.87%) Dec 19, 4:00PM EST
    |After Hours : 133.56 Down 0.00 (0.00%) Dec 19, 6:58PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 1,116,984   916,076   743,183  
    Cost of Revenue131,127  119,297  88,904  
    Gross Profit 985,857   796,779   654,279  
    Operating Expenses
    Research Development299,348  173,387  180,015  
    Selling General and Administrative394,010  201,746  156,482  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 292,499   421,646   317,782  
    Income from Continuing Operations
    Total Other Income/Expenses Net4,462  35,664  2,702  
    Earnings Before Interest And Taxes296,961  457,310  320,484  
    Interest Expense18,058  16,639  21,367  
    Income Before Tax278,903  440,671  299,117  
    Income Tax Expense104,343  136,229  81,874  
    Minority Interest -   -   -  
    Net Income From Continuing Ops174,560  304,442  217,243  
    Non-recurring Events
    Discontinued Operations -   -  625  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 174,560   304,442   217,868  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 174,560   304,442   217,868  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.